Drawing for I PEACE

USPTO serial 88596074

I PEACE

Reviewed by CopyMark Law Group

Reg. 6420635Status 700Renewal
Filing date
Status date
Registration date
Jul 13, 2021
Examiner
CLARK, ANDREW T
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with I PEACE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,795*

Plus Government fees of $1,625

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Andrew N. Spivak

Andrew N. Spivak MOSAIC LEGAL GROUP, PLLC5185 MACARTHUR BOULEVARD, NW, SUITE 350WASHINGTON, DC 20016-3341UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
010Apparatus for the regeneration of stem cells for medical purposes, namely, for gene editing, gene collection, and gene productionACTIVE—
011Refrigerated medical container for storage, transportation and cooling of medicines and pharmaceuticals, namely, frozen storage containers for stem cellsACTIVE—
040Manufacture of medical devices to order and/or specification of others; biomanufacturing for others, namely, manufacturing of medical and biological materials; manufacture of machinery for generating stem cells to order and/or specification of others; biomanufacturing for others, namely, manufacturing of clinical grade cellsACTIVE—
042Scientific and medical research in the field of stem cell, gene research, and gene editing; blood analysis services; medical and scientific research, namely, testing, inspection, and research of stem cells; biological cloning services, namely, organ reproduction services; biological cloning services, namely, DNA, RNA and protein reproduction services; testing, inspection, and research of cosmetics; Collection of biological materials, namely, stem cells for scientific research purposes; medical and scientific research services, namely, research in the field of stem cells and gene diagnostics; DNA analysis services for scientific research purposes; drug discovery services; scientific research services, namely, research in the field of regenerative medicine; stem cell and gene expression analysis for scientific research purposes; stem cell and epigenetic state analysis for scientific research purposes; proteomic analysis for scientific research purposesACTIVE—
044Stem cell and gene collection services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories in the nature of stem cell and gene expression analysis; medical analysis services for diagnostic and treatment purposes provided by medical laboratories in the nature of stem cell and epigenetic state analysis; medical analysis services for diagnostic and treatment purposes provided by medical laboratories in the nature of proteomic analysis; healthcare; medical assistance; stem cell therapy and stem cell production services; stem cell and gene banking services; stem cell banking in the nature of stem cell freezing services; cosmetic surgery services; stem cell therapy services, namely, stem cell and gene transplantation services; collection of biological materials, namely, stem cells for medical treatment purposes; medical analysis services for diagnostic and treatment purposes provided by medical laboratories in the nature of stem cell and gene diagnostic services; medical diagnostic and treatment services in the field of regenerative medical servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 13, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jul 13, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 8, 2021SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jun 7, 2021CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
May 10, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 10, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 10, 2021CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 21, 2021SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Apr 21, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 7, 2021IUAFUSE AMENDMENT FILED—
Apr 7, 2021EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Oct 6, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 2, 2020EX1GSOU EXTENSION 1 GRANTED—
Oct 2, 2020EXT1SOU EXTENSION 1 FILED—
Oct 2, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 7, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 11, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 11, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 22, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 6, 2020ALIEASSIGNED TO LIE—
Dec 31, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 20, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Dec 20, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 20, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 20, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 6, 2019DOCKASSIGNED TO EXAMINER—
Dec 2, 2019DOCKASSIGNED TO EXAMINER—
Sep 10, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 31, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance